Robert Steinbach
Robert Steinbach
Universitätsklinik für Neurologie Jena
Verified email at
Cited by
Cited by
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ...
Nature genetics 53 (12), 1636-1648, 2021
Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis
S Witzel, A Maier, R Steinbach, J Grosskreutz, JC Koch, A Sarikidi, S Petri, ...
JAMA neurology 79 (2), 121-130, 2022
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
E Jochmann, R Steinbach, T Jochmann, HY Chung, A Rödiger, ...
Therapeutic advances in neurological disorders 13, 1756286420907803, 2020
Cerebrospinal fluid neurofilament light chain (NFL) predicts disease aggressiveness in amyotrophic lateral sclerosis: an application of the D50 disease progression model
M Dreger, R Steinbach, N Gaur, K Metzner, B Stubendorff, OW Witte, ...
Frontiers in neuroscience 15, 651651, 2021
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy
A Pechmann, M Behrens, K Dörnbrack, A Tassoni, S Stein, S Vogt, ...
Brain 146 (2), 668-677, 2023
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
M Dreger, R Steinbach, M Otto, MR Turner, J Grosskreutz
Journal of Neurology, Neurosurgery & Psychiatry 93 (4), 422-435, 2022
Structural hallmarks of amyotrophic lateral sclerosis progression revealed by probabilistic fiber tractography
R Steinbach, K Loewe, J Kaufmann, J Machts, K Kollewe, S Petri, ...
Journal of neurology 262, 2257-2270, 2015
Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis
R Steinbach, M Batyrbekova, N Gaur, A Voss, B Stubendorff, TE Mayer, ...
NeuroImage: Clinical 25, 102094, 2020
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
T Meyer, A Maier, Z Uzelac, T Hagenacker, R Günther, O Schreiber‐Katz, ...
European Journal of Neurology 28 (8), 2582-2595, 2021
Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics
J Thome, R Steinbach, J Grosskreutz, D Durstewitz, G Koppe
Human brain mapping 43 (2), 681-699, 2022
Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model
R Steinbach, N Gaur, A Roediger, TE Mayer, OW Witte, T Prell, ...
Human Brain Mapping 42 (3), 737-752, 2021
Symptomatic pharmacotherapy in ALS: Data analysis from a platform-based medication management programme
T Meyer, D Kettemann, A Maier, T Grehl, U Weyen, J Grosskreutz, ...
Journal of Neurology, Neurosurgery & Psychiatry 91 (7), 783-785, 2020
Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
T Prell, N Gaur, R Steinbach, OW Witte, J Grosskreutz
Health and Quality of Life Outcomes 18, 1-5, 2020
Remote digital assessment of amyotrophic lateral sclerosis functional rating scale–a multicenter observational study
T Meyer, S Spittel, T Grehl, U Weyen, R Steinbach, D Kettemann, S Petri, ...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24 (3-4), 175-184, 2023
Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy
DC Schorling, H Kölbel, A Hentschel, A Pechmann, N Meyer, B Wirth, ...
European Journal of Neurology 29 (7), 2084-2096, 2022
Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
R Steinbach, T Prell, N Gaur, A Roediger, C Gaser, TE Mayer, OW Witte, ...
NeuroImage: Clinical 30, 102674, 2021
Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
N Dieckmann, A Roediger, T Prell, S Schuster, M Herdick, TE Mayer, ...
NeuroImage: Clinical 36, 103162, 2022
Developing a neuroimaging biomarker for amyotrophic lateral sclerosis: multi-center data sharing and the road to a “Global Cohort”
R Steinbach, N Gaur, B Stubendorff, OW Witte, J Grosskreutz
Frontiers in Neurology 9, 1055, 2018
Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
R Steinbach, T Prell, N Gaur, B Stubendorff, A Roediger, B Ilse, OW Witte, ...
Journal of clinical medicine 9 (9), 2873, 2020
Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations
M Wiesenfarth, K Günther, K Müller, S Witzel, U Weiland, K Mayer, ...
Brain Communications 5 (2), fcad087, 2023
The system can't perform the operation now. Try again later.
Articles 1–20